Skip to main content

ONU 300 (Onureg 300 mg)

Generic Name: azacitidine

Pill with imprint ONU 300 is Brown, Elliptical / Oval and has been identified as Onureg 300 mg. It is supplied by Bristol-Myers Squibb Company.

Onureg is used in the treatment of acute myeloid leukemia and belongs to the drug class miscellaneous antineoplastics. There is positive evidence of human fetal risk during pregnancy. Onureg 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ONU 300

Onureg 300 mg ONU 300

Onureg

Generic Name
azacitidine
Imprint
ONU 300
Strength
300 mg
Color
Brown
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Miscellaneous antineoplastics
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Bristol-Myers Squibb Company
National Drug Code (NDC)
59572-0740

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.